Abstract 3184
Background
Although nivolumab has been widely adopted as a treatment for advanced RCC, only a minority of pts benefit. We aimed to use radiomics as a predictive biomarker. By extracting quantitative information from serial imaging, this non-invasive method captures the spatial and temporal heterogeneity of tumors, more than tissue biopsy. We hypothesized to find an imaging correlate of host immune recognition, characterized by infiltration of the invasive tumor margin by immune effector cells, that would identify pts to benefit from nivolumab.
Methods
We retrospectively identified all advanced RCC pts treated with nivolumab at our institution from 2013-2017. Pts were labelled as responders (CR / PR / durable SD) or non-responders based on clinical data. For each pt, lesions were contoured from pre-treatment and first on-treatment CT scans. All lesions were manually contoured in tandem by two trained investigators. This information was used to train a radial basis function support vector machine classifier to learn a prediction rule to distinguish responders versus non-responders. The classifier was internally validated by 10-fold nested cross-validation.
Results
37 pts were identified. Excluded: imaging unavailable = 3, incompatible CT protocols = 7. 104 lesions were contoured from 27 pts. Median age 56 years, 78% male, 89% clear cell histology, 89% prior nephrectomy, 89% prior systemic therapy. 19 responders vs 8 non-responders. Lesions: 60% lymph nodes, 23% lung metastases, 17% renal/adrenal metastases. For the classifier trained on the baseline CT scans, 69% accuracy was achieved. For the classifier trained on the first on-treatment CT scans, 66% accuracy was achieved.
Conclusions
Based on preliminary computations, the radiomics signature could discriminate nivolumab responders from non-responders. Additional texture feature analysis with over 72 billion calculations is underway to improve the classifier performance to discriminate tumor responses to immunotherapy. External validation against the comprehensive patient dataset from the International Metastatic Renal Cell Cancer Database Consortium is planned.
Clinical trial identification
Legal entity responsible for the study
Dr Hao-Wen Sim and Dr Aaron Hansen.
Funding
Awarded $40,000 from peer-reviewed 2017 GUMOC Astellas Research Grant.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2069 - The concordance with antiemetic guideline for pediatric, adolescent and young adult patients with cancer using a large-scale administrative database.
Presenter: Seiko Bun
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2740 - Effectiveness of surgical glove compression therapy as a prophylactic method against nab-Paclitaxel induced peripheral neuropathy
Presenter: Shigeru Tsuyuki
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2229 - Effect of oral magnesium supplementation on the kinetics of magnesium wasting induced by EGFR targeted antibody therapy for colorectal carcinoma (MAGNET trial)
Presenter: Hubert Piessevaux
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4155 - Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV)
Presenter: Antony Mersiades
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2473 - Pregnancies after breast cancer, is there a real need for fertility preservation ? Results from the ARTEMIS cohort of 60 young patients
Presenter: Jerome Martin-Babau
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3450 - Inclusion of adolescents in adult early phase trials and young adults in paediatric early phase trials: a reality or a myth?
Presenter: Aurore Vozy
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2917 - Indicators of non-uptake of breast cancer screening: results from the EDIFICE 6 survey
Presenter: Jean-Francois Morere
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2920 - Benefits of physical activity and sport integrated into the care pathway of oncology patient
Presenter: Laurence Vanlemmens
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
5334 - Identifying barriers to physical activity in patients with lung cancer: an Australian pilot study
Presenter: Quan Tran
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
6108 - Quality of life, late effects, and related clinical factors among Korean colorectal cancer survivors
Presenter: Ji Soo Park
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract